AzTrials
AzTrials

Clitoris VascularityNCT06084728

3D Ultrasound and Color Doppler Studies of the Clitoris in Pregnant Women

An observational study of Clitoris Vascularity, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients will be divided into two groups: Group A: 30 pregnant women Group B: 30 non pregnant women as control group. All patients will be subjected to the following: 1. Interview with women for detailed history taking and explaining the research. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Clitoris Vascularity
What is being tested?
Color Doppler ultrasonography
How many people
60 participants
Where
1 siteEgypt
Study dates
Aug 2024to Aug 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Both pregnant and non pregnant women between 18 and 45 years old

Who may be able to join

  • Both pregnant and non pregnant women between 18 and 45 years old

Who cannot join

  • Women with genital anomalies
  • Virgins
  • Women with gynecological disorders as endometriosis or pelvic pathology causing pelvic congestion
  • Genital inflammations or mases Neurological or vascular disorders

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Kasr Alainy medical school

    Cairo, 12111

Other trials in Egypt

About this study

Patients will be divided into two groups:

Group A: 30 pregnant women Group B: 30 non pregnant women as control group.

Read more

All patients will be subjected to the following:

  1. Interview with women for detailed history taking and explaining the research. A written Consent will be obtained from them before their enrollment into the study.
  2. To ensure standard conditions, the subjects will lie in a recumbent position and were evaluated between 08.00 and 11.00 a.m. To avoid anyexternal genital stimulation, subjects will be asked not to wear trousers or cross their legs on the morning of the ultrasound examination.
  3. Furthermore, in order to minimize external effects on blood flow, all women will be scanned in a noiseless room with constant heat and light
Read the detailed description

Patients will be divided into two groups:

Group A: 30 pregnant women Group B: 30 non pregnant women as control group. Translabial ultrasound scanning will be performed for each woman with Sonographic measurements of the clitoral volume and labia minora thickness performed by using a RSP-16 multi frequency transducer. The transducer will be placed on the upper part of the vulva to assess the clitoris in a transverse section and on the labia majora for the sagittal view. To prevent artifacts, care will be taken to avoid excessive pressure on the clitoris. The clitoris was studied where the paired corpora join in a single body that projects into the glans. Volumes were measured by reporting length, width, and depth assuming the form to be an ellipsoid: V = π/6 × D1 × D2 × D3, where D1, D2, and D3 are the maximal longitudinal, anteroposterior, and transverse diameter, respectively. The same transducer will be sagittally placed on each labium major to measure labia minora thickness, ensuring that the minimum possible pressure is applied with the ultrasound probe on the skin.

Color Doppler ultrasonography will be used to identify, in a longitudinal plane, the dorsal clitoral artery, which is sampled on the outer surface of the clitoral body as previously described. With the same longitudinal approach, the terminal branch of the posterior labial artery (a branch of the internal pudendal artery) will be visualized posterolaterally to the labia majora (at about 2 cm from the clitoral hood).

Being tested
Color Doppler ultrasonography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Color Doppler ultrasonographyDiagnostic test

    Also called Doppler

    in a longitudinal plane, the dorsal clitoral artery, which is sampled on the outer surface of the clitoral body as previously described. With the same longitudinal approach, the terminal branch of the posterior labial artery (a branch of the internal pudendal artery) was visualized posterolaterally to the labia majora

Study groups in NCT06084728
Study groupRoleWhat they receive
Pregnant women30 pregnant women.
Receives: Diagnostic Test: Color Doppler ultrasonography
Non-pregnant women30 non pregnant women as control group
Receives: Diagnostic Test: Color Doppler ultrasonography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The peak systolic velocity of the clitoreal artery

    The peak systolic velocity of the clitoreal artery using Doppler machine to measure Blood supply to the body of clitoris in cm/second

    Measured: At time of Doppler assessment

  2. The pulsatility index of clitoreal artery

    The pulsatility index of clitoreal artery using Doppler machine to measure Blood supply to the body of clitoris in cm/second

    Measured: At time of Doppler assessment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Oct 2023
  2. Study startAug 2024 (estimated)
  3. Primary completionJul 2025 (estimated)
  4. Study completionAug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06084728
Sponsor's protocol ID
72
Status last verified
Jun 2024
First submitted
1 Oct 2023
Last updated
20 Jun 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Clitoris Vascularity, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mostafa Seleem, MD (+201001413128, mostafasaleem@kasralainy.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The peak systolic velocity of the clitoreal artery (time frame: At time of Doppler assessment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in